Roche’s antiviral hits flu targets in PhIII trial
Roche says its investigational flu drug baloxavir marboxil, in-licensed from Japan's Shionogi, has met key goals in a late-stage trial. [...]
Tue, Jul 17, 2018
Pfizer kicks off PhIII programme for haemophilia B gene therapy
Pfizer has kicked off a late-stage trial assessing efficacy and safety of the investigational gene therapy fidanacogene elaparvovec for the treatment of haemophilia B. [...]
Tue, Jul 17, 2018
UK panel says human embryo editing ‘morally permissable’
An independent ethics panel in the UK has concluded that genome editing to influence the characteristics of a future person could be “morally permissible”. [...]
Tue, Jul 17, 2018
NICE issues cerebral palsy guideline for adults
The National Institute for Health and Care Excellence has published a new guideline that aims to address current variation in the provision of services for adults with cerebral palsy. [...]
Tue, Jul 17, 2018

 

The Learning  Partnership